ANVISA Approval [Regulatives / Guidelines]

posted by H_Rotter – Germany, 2006-01-27 15:00 (6752 d 00:03 ago) – Posting: # 68
Views: 12,557

Dear shiv,

it's different from the FDA.
The center(s) performing the study must follow ANVISA's rules (http://www.anvisa.gov.br/eng/legis/resol/103_03rdc_e.htm), must be inspected (http://www.anvisa.gov.br/eng/bio/form_bio.doc), and renew their status anually (http://www.anvisa.gov.br/eng/bio/form_renewal.rtf). After approval of the protocol by the local IEC, the study may be performed.

Only if your protocol deviates from ANVISA's standards (e.g. if you want to perform at multiple dose study in order to reduce variability for HVDs), I would strongly recommend contacting them before.

good luck!
Hermann Rotter

Complete thread:

UA Flag
Activity
 Admin contact
23,117 posts in 4,859 threads, 1,647 registered users;
23 visitors (0 registered, 23 guests [including 7 identified bots]).
Forum time: 16:03 CEST (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5